Joyance 2

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

IDUN Technologies AG is a Swiss neurotechnology startup founded in 2017, specializing in the design and manufacture of advanced biosensors for wearable devices. The company’s flagship product, DRYODES, features dry conductive electrodes that facilitate bio-potential monitoring, including electrocardiography (ECG), electroencephalography (EEG), and electromyography (EMG). IDUN Technologies aims to integrate neuroscience into everyday products, allowing connected devices to understand and respond to users' emotional needs through real-time neuro-markers. By developing innovative biosensor technology and a comprehensive neurofeedback value chain—from electrode manufacturing to product integration—IDUN enables industries to harness brain signal monitoring for enhanced user experiences. The company's Guardian Neuro-Intelligence Platform exemplifies this approach, utilizing in-ear EEGs to provide actionable insights that improve product design and interaction. Through this integration of emotion intelligence and connected devices, IDUN Technologies aspires to foster a more connected and empathetic world.

Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.

Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.

Zone7 is a technology company founded in 2017 and based in Palo Alto, California, specializing in artificial intelligence-driven sports injury prediction software. The platform leverages data from wearable devices, medical records, and fitness profiles to forecast potential injuries, allowing for proactive measures to enhance athlete safety and performance. Zone7 serves over 30 professional sports franchises, offering insights that enable coaching staff to monitor athlete performance and injury risk effectively. Additionally, the technology is utilized in hospitals to ensure the well-being of medical staff by providing actionable recommendations for optimizing workload and recovery. By analyzing various data sources, Zone7 aims to protect and enhance the health and performance of both athletes and the elite workforce.

Nanoleq AG, established in 2017 and based in Zurich, Switzerland, specializes in the development and manufacturing of innovative electric cables using stretchable electronics. As a spinoff from ETH Zurich, the company focuses on integrating electronic functionalities into textiles, particularly for health monitoring. Its products utilize advanced conductive silicone technology to create soft sensors capable of recording vital signs such as heartbeat, electrocardiograms, and breathing patterns through comfortable and washable garments. These sensors are designed for various applications, including healthcare, sports, and workwear, with the aim of setting a standard in the health-monitoring textile market. Nanoleq is committed to facilitating the rapid development and widespread adoption of smart textiles across multiple sectors, including robotics and aerospace.

Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on restless leg syndrome. Its innovative device utilizes neural circuitry to alleviate symptoms and promote undisturbed sleep, empowering patients to better manage their chronic medical conditions.

H2L Inc. is a Tokyo-based company that focuses on researching and developing electric stimulation devices to enhance human interaction with virtual environments. Founded in 2012, H2L offers innovative products such as UnlimitedHand, a virtual reality gaming controller that utilizes electronic muscle stimulation to enable users to control finger movements and experience touch in a virtual space. Additionally, the company markets PossessedHand, a device worn on the forearm that applies electrical stimuli to control finger movements, making it suitable for rehabilitation and learning support applications. H2L is also exploring technologies that facilitate shared body experiences between users and virtual avatars, enhancing engagement in gaming and immersive environments.

Embr Labs Inc. is a company based in Somerville, Massachusetts, that specializes in developing thermal comfort devices aimed at enhancing human well-being. Founded in 2014 and originally known as Wristify Inc., Embr Labs has created innovative technology that uses temperature to influence the autonomic nervous system, helping users manage conditions such as hot flashes, sleep disturbances, and anxiety. The company's wearable devices, combined with a mobile app and cloud infrastructure, provide a unique platform for thermal stimulation and digital interventions, allowing users to track and manage their symptoms effectively. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology originated from the founders' work as engineering students at MIT and has received significant backing from investors and over $2.5 million in grants from various organizations.

Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Figur8, Inc. is a Boston-based company that specializes in developing advanced wearable sensors to monitor body movement as a biomarker for musculoskeletal (MSK) conditions. Founded in 2016 as a spin-off from MIT, Figur8 combines smart biosensors, intuitive software, and artificial intelligence to analyze MSK health data. The technology captures three-dimensional skeletal movement and muscle output, allowing for objective assessment of musculoskeletal performance and recovery. This innovative solution provides valuable insights throughout the entire care process, from injury to full recovery, ultimately reducing healthcare costs, improving access to treatment, and empowering patients to manage their own MSK health effectively.

IrisVision is the global leader in digital vision technologies. We have developed the world’s first and only smart visual assistive device built on wearable VR technology to help millions of vision-impaired people regain their sight, achieve independence, and do the things they love.

Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

Neurosity Inc., founded in 2018 and based in New York, specializes in thought-powered wearable devices that interpret brain activity to enhance productivity and focus. The company's flagship product, the Notion, integrates hardware and software to help users, particularly programmers, improve their concentration and extend their focus time. By utilizing brain wave data, Neurosity's neural devices facilitate a deeper understanding of thoughts, feelings, and movements, allowing users to translate their cognitive states into actionable outputs. This innovative approach empowers individuals to measure their brain activity and engage with personalized applications directly on the device, fostering new experiences driven by their thoughts.

Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company founded in 2017 that specializes in developing and commercializing a wearable microfluidic sensing platform. This innovative technology analyzes small droplets of sweat directly from the skin to provide insights into health, hydration, and athletic performance. The platform is designed to measure various biomarkers, including proteomics and inflammatory markers, allowing for personalized management of health and nutrition. Epicore's approach leverages over two decades of research in microfluidics and soft materials conducted by leading experts at Northwestern University. By offering a non-invasive and cost-effective solution, Epicore aims to enhance athletic performance and improve overall health monitoring for users.

Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in developing therapeutic wearable devices aimed at treating chronic neurological and sleep disorders, particularly focusing on restless leg syndrome. Its innovative device utilizes neural circuitry to alleviate symptoms and promote undisturbed sleep, empowering patients to better manage their chronic medical conditions.

Flux Bioscience is a company that originated from Stanford University, focusing on innovative point-of-care in vitro medical diagnostics. It has developed a portable biosensor platform designed to deliver medical-grade diagnostics directly to patients' homes. Utilizing a technology initially designed for reading and writing computer hard drives, Flux's platform analyzes blood, urine, or saliva samples to measure various biomarkers related to exercise, stress, fertility, and diet. These measurements are correlated with sleep and activity data obtained from wearable technologies. The biosensors are equipped with biochips that can detect multiple biomarkers simultaneously, providing accurate and sensitive real-time results through antibody-antigen interactions with magnetic nanoparticles. This approach empowers individuals to take charge of their healthcare and make informed lifestyle decisions.

Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.